A Cluster Randomized Trial of an mHealth Intervention for Adolescents With Congenital Heart Disease: Rationale and Design of the READYorNot CHD Study

Résumé fourni par la source

The population of adolescents with congenital heart disease (CHD) is growing exponentially and requires transition preparation for adult-oriented health care. Nurse-led transition programs are effective in improving CHD knowledge and self-management skills. However, many clinical programs lack the human resources needed to provide transition services. Mobile health applications have the potential to prepare transition-age youth for entering adult health care. However, there are no outcome data on the impact and effectiveness of CHD transition applications. Accordingly, in partnership with a Youth Advisory Council, we developed the MyREADY Transition CHD App (the App) designed to enhance youth CHD knowledge and self-management skills. The READYorNot CHD study is a multicenter, cluster randomized noninferiority clinical trial that is evaluating the efficacy of the App plus limited nurse teaching (intervention), vs comprehensive nurse-only teaching (control) for 16- to 17-year-olds with moderate or complex CHD. Participants are being enrolled in clusters based on week of attendance in the pediatric cardiology clinic, with a 1:1 allocation between intervention vs control and target recruitment of 204 participants. The primary outcome is the change in Transition Readiness Assessment Questionnaire score from baseline to 18 months. Secondary outcomes are change in CHD knowledge score, self-efficacy, and time to first adult CHD appointment. Semistructured interviews will provide additional insights into the advantages and disadvantages of the App vs nurse-only teaching. This study will inform patients, pediatric cardiology programs, and policy makers in judging whether this mobile health intervention warrants widespread availability in clinical settings to improve transition outcomes of adolescents with CHD. Clinical Trial Registration: NCT04463446.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.